License fees include periodic milestone payments, research and development contract fees and the amortization of upfront payments received from licensing partners. Merck KGaA’s subsidiary Merck Serono ...

AEterna Zentaris Inc. (Nasdaq: AEZS) has agreed to sell Cowen Healthcare Royalty Partners its rights to royalties on future sales of Cetrotide, covered by AEterna’s license agreement with Merck Serono ...

AEterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, announces that it has completed the transaction under the previously ...

Cetrotide, a drug commonly used by women undergoing in vitro fertilization, will not be available in parts of Europe because of an unidentified production issue with its manufacturer, Merck KGaA. The ...

AEterna Zentaris (AEZS) Agrees to Sell Cetrotide Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners Quebec City, Canada, November 12, 2008 - Æterna Zentaris Inc. (NASDAQ: AEZS; TSX: ...

Cetrorelix acetate for injection is a generic to EMD Serono’s Cetrotide (0.25 mg). Cetrorelix acetate for injection is available immediately from Fresenius Kabi in a kit that contains one single-dose ...

“We are pleased to announce the first approved AP-rated generic option for women receiving fertility treatments,” said Akorn president and CEO Douglas Boothe. “As an increasing number of infants are ...

The ‘Cetrotide Market study‘ 2020 offers an in-depth analysis pertaining to potential drivers fueling this industry. The study also elucidates valuable insights about profitability position, market ...

Aeterna Zentaris Inc. AEZS AEZ (the "Company") today announced the successful completion of its previously announced agreements with various partners and licensees with respect to the manufacturing ...

Aeterna Zentaris’ German subsidiary transferred manufacturing rights and granted a manufacturing license for Cetrotide® to Merck Serono. The deal is expected to be finalized on or about October 1, ...

Aeterna Zentaris Inc. 's ( AEZS) source of revenue includes sales, royalties and license fees. Sales are derived from Cetrotide and royalties are derived indirectly from Merck KGaA 's ( MKGAF) net ...

(the "Company") today announced that its German subsidiary has entered into binding agreements with various partners and licensees with respect to the manufacturing rights and obligations for its ...